IGC Pharma (IGC) Asset Utilization Ratio (2011 - 2025)

IGC Pharma (IGC) has reported Asset Utilization Ratio for 15 consecutive years, with 0.16 the latest figure, recorded in Q3 2025.

• On a quarterly basis, Asset Utilization Ratio rose 43.88% year-over-year to 0.16 in Q3 2025; TTM through Sep 2025 was 0.16, a 43.88% increase from a year earlier, with the FY2026 full-year figure at 0.04, down 74.06% from the prior year.
• Asset Utilization Ratio was 0.16 for Q3 2025 at IGC Pharma, down from 0.2 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.2 in Q2 2025 and troughed at 0.01 in Q3 2021.
• A 5-year average of 0.08 and a median of 0.08 in 2023 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio tumbled 89.41% in 2021 and surged 277.81% in 2022, its largest moves.
• Over 5 years, Asset Utilization Ratio stood at 0.01 in 2021, then surged by 277.81% to 0.04 in 2022, then soared by 112.06% to 0.09 in 2023, then soared by 45.12% to 0.13 in 2024, then advanced by 27.75% to 0.16 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.16 (Q3 2025), 0.2 (Q2 2025), and 0.14 (Q1 2025), per Business Quant data.